Dr. Christopher R. Foss
Claim this profilePresbyterian Intercommunity Hospital
Area of expertise
Fallopian Tube Cancer
Christopher R. Foss has run 2 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Ovarian Cancer
Christopher R. Foss has run 2 trials for Ovarian Cancer. Some of their research focus areas include:
Affiliated Hospitals
Presbyterian Intercommunity Hospital
Clinical Trials Christopher R. Foss is currently running
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting
1 award
Phase 2
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about Christopher R. Foss
Clinical Trial Related
2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Christopher R. Foss has experience with
- Binimetinib
- Fluorouracil
- Nilotinib Hydrochloride Monohydrate
- Olaparib
- Oxaliplatin
- Paclitaxel
Breakdown of trials Christopher R. Foss has run
Fallopian Tube Cancer
Ovarian Cancer
Endometrial Cancer
Peritoneal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher R. Foss specialize in?
Christopher R. Foss focuses on Fallopian Tube Cancer and Ovarian Cancer. In particular, much of their work with Fallopian Tube Cancer has involved Stage IV patients, or patients who are Stage III.
Is Christopher R. Foss currently recruiting for clinical trials?
Yes, Christopher R. Foss is currently recruiting for 2 clinical trials in Whittier California. If you're interested in participating, you should apply.
Are there any treatments that Christopher R. Foss has studied deeply?
Yes, Christopher R. Foss has studied treatments such as Binimetinib, Fluorouracil, Nilotinib Hydrochloride Monohydrate.
What is the best way to schedule an appointment with Christopher R. Foss?
Apply for one of the trials that Christopher R. Foss is conducting.
What is the office address of Christopher R. Foss?
The office of Christopher R. Foss is located at: Presbyterian Intercommunity Hospital, Whittier, California 90602 United States. This is the address for their practice at the Presbyterian Intercommunity Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.